Dyne Therapeutics, Inc. · NASDAQ:DYN
T. Rowe Price Investment Management, Inc. reported a 18.70% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Investment Management, Inc. reported a 18.70% stake in Dyne Therapeutics, Inc., 30,785,801 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 18.70%
- Shares
- 30,785,801
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.70% | 30,785,801 |
Source
Related
- Dyne Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Mar 6, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Jan 8, 2026
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026